SUBSCRIBE
SUBSCRIBE

EU Drugs Regulator Reviews Safety of GlaxoSmithKline’s Flu Jab, Probes Swine Flu Shot, Narcolepsy Link

August 27, 2010 | 
1 min read
LONDON (Reuters) - Europe's drug regulator is reviewing the safety of GlaxoSmithKline's Pandemrix flu vaccine, which has been given to more than 30 million people in Europe, to investigate possible links to a sleep disorder.
Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Illustration showing large scissors cutting employees in half
Layoffs
The 5 Largest Biopharma Layoffs of Q1 2025: Updated
May 13, 2025
 · 
5 min read
 · 
Angela Gabriel
European Union flags in front of the blurred European Parliament in Brussels, Belgium
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
April 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Courtesy of Sarepta Therapeutics
Duchenne muscular dystrophy
Committee Recommends EU Trials of Sarepta’s Elevidys Continue, Day After Holds
April 4, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Alzheimer’s disease
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi
March 28, 2025
 · 
2 min read
 · 
Dan Samorodnitsky